Back to Journals » Diabetes, Metabolic Syndrome and Obesity
Diabetes, Metabolic Syndrome and Obesity
- View all (3377)
- Volume 19, 2026 (115)
- Volume 18, 2025 (389)
- Volume 17, 2024 (428)
- Volume 16, 2023 (373)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Journal Articles:
- From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM) and Emerging Diabetes Management Technologies on Metabolic Health (1)
- GLP-1 Agonists: The Game-Changers in Type 2 Diabetes and Obesity Care (4)
- The State of Diabetes, Metabolic Syndrome and Obesity (9)
- Managing obesity with pharmacotherapy (7)
- Understanding the Impact of Gender and Sex on Diabetes Incidence, Complications, and Treatment (1)
- Emerging therapeutic targets of diabetic nephropathy (1)
Identification of Continuous Glucose Monitoring Self-Management Structured Education Programs for People with Type 1 Diabetes Mellitus: A Mixed Methodology Systematic Review
Pizirtzidou E, Karagkounis C, Bellali T, Katsiki N, Kazakos K, Muzurović E, Minasidou E
Diabetes, Metabolic Syndrome and Obesity 2026, 19:598765
Published Date: 12 May 2026
Community Pharmacists’ Knowledge and Counseling Competence on GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes Care in Türkiye: A Cross-Sectional Study
Bayram-Ozgur D, Demirtürk E, Sar Y
Diabetes, Metabolic Syndrome and Obesity 2026, 19:587750
Published Date: 3 March 2026
GLP-1 Receptor Agonist Therapy in Older Adults with Diabetes: A Qualitative Analysis of Phase 4 ClinicalTrials.gov Studies
Alourfi NM, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2026, 19:584052
Published Date: 3 February 2026
Confluence of Diabetes Risk
Keenan HA
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4659-4660
Published Date: 20 December 2025
Revolutionizing Diabetes Care: From Tech to Therapeutics
Akturk HK, Waterman LA, Cobry EC
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4675-4682
Published Date: 20 December 2025
Diabetes: A Subspecialty of Medicine and a Matter of Public Health
Conway RB
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4645-4650
Published Date: 20 December 2025
Metabolic Disorders and Complications
Sull JW, McClain DA
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4661-4663
Published Date: 20 December 2025
Subphenotyping Obesity in Pursuit of Personalized Medicine: The Devil is in the Details
McClain DA
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4671-4673
Published Date: 20 December 2025
Editorial: Lipidology at the Dawn of a New Era
Corral P
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4665-4666
Published Date: 20 December 2025
The New Era of “Diabetes Prevention, Care and Management”: Precision Tools, Predictive Models and New Technologies
Carafa A, Maddaloni E
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4655-4657
Published Date: 20 December 2025
The Future of Obesity Management: Bridging Pharmacologic Innovation and Public Health
Qian F, Wang L
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4667-4670
Published Date: 20 December 2025
The Rise and Rise of Type 1 and Type 2 Diabetes in Youth
DeBoer MD
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4651-4654
Published Date: 20 December 2025
Effects of GLP-1RA Treatment on Long-Term Post-PCI Prognosis in T2DM Patients: A Propensity Score Matching Study
Fang B, Liu F, Luo J, Song N, Liu C, Ji W, An X, Xie Q, Yang Y, Li X
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3031-3040
Published Date: 25 August 2025
Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss in Patients with Obesity or Overweight: A Systematic Review
Xie Z, Liang Z, Xie Y, Zheng G, Cao W
Diabetes, Metabolic Syndrome and Obesity 2025, 18:2837-2849
Published Date: 12 August 2025
Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
Cheney C, Hunter K, Klein M
Diabetes, Metabolic Syndrome and Obesity 2025, 18:1411-1418
Published Date: 2 May 2025
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets
Reed J, Bain SC, Kanamarlapudi V
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2419-2456
Published Date: 13 June 2024
Effect of SophorOx® on Oxidative Stress and Body Composition in Individuals with High BMI: A Randomized Controlled Trial
Roza JM, Srivastava S
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2221-2234
Published Date: 5 June 2024
DR10627, a Novel Dual Glucagon‑like Peptide‑1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus
Shao Y, Chen Y, Zhu M, Liu Y, Fang C, Wang M, Sun P, Fu W, Huang J, Sheng S, Huang Y
Diabetes, Metabolic Syndrome and Obesity 2024, 17:1563-1573
Published Date: 6 April 2024
Gender Differences in the Incidence of Nephropathy and Changes in Renal Function in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Zhang F, Han Y, Zheng G, Li W
Diabetes, Metabolic Syndrome and Obesity 2024, 17:943-957
Published Date: 26 February 2024
The Effect of Tirzepatide on Weight, Lipid Metabolism and Blood Pressure in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Lv X, Wang H, Chen C, Zhao Y, Li K, Wang Y, Wang L, Fu S, Liu J
Diabetes, Metabolic Syndrome and Obesity 2024, 17:701-714
Published Date: 12 February 2024
The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity
Dalle Grave R
Diabetes, Metabolic Syndrome and Obesity 2024, 17:227-230
Published Date: 15 January 2024
Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Patients with Overweight/Obesity
She D, Xu W, Liu J, Zhang Z, Fang P, Li R, Kong D, Xuan M, Liu Q, Pan MY, Wang Y, Xue Y
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3007-3017
Published Date: 28 September 2023
The Role of PKM2 in Diabetic Microangiopathy
Tu C, Wang L, Wei L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1405-1412
Published Date: 4 May 2022